Edward V. Hannigan
About
Edward V. Hannigan is a scholar working on Reproductive Medicine, Epidemiology and Obstetrics and Gynecology.
According to data from OpenAlex, Edward V. Hannigan has authored 80 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Reproductive Medicine, 26 papers in Epidemiology and 26 papers in Obstetrics and Gynecology. Recurrent topics in Edward V. Hannigan's work include Ovarian cancer diagnosis and treatment (28 papers), Cervical Cancer and HPV Research (22 papers) and Endometrial and Cervical Cancer Treatments (20 papers). Edward V. Hannigan is often cited by papers focused on Ovarian cancer diagnosis and treatment (28 papers), Cervical Cancer and HPV Research (22 papers) and Endometrial and Cervical Cancer Treatments (20 papers). Edward V. Hannigan collaborates with scholars based in United States, Myanmar and Switzerland. Edward V. Hannigan's co-authors include Daniel L. Clarke‐Pearson, David S. Alberts, Brian N. Bundy, Shu‐Yuan Liao, John H. Malfetano, William T. Sause, Wesley C. Fowler, Charles W. Whitney, Robert V. O’Toole and Tung Van Dinh and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
In The Last Decade
Edward V. Hannigan
77 papers receiving 4.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Edward V. Hannigan United States | 29 | 2.0k | 1.9k | 1.9k | 958 | 875 | 80 | 4.3k | ||
| Hervy E. Averette United States | 37 | 2.4k 1.2× | 1.6k 0.8× | 1.5k 0.8× | 1.5k 1.6× | 1.3k 1.5× | 162 | 4.8k | ||
| David H. Moore United States | 33 | 2.0k 1.0× | 1.4k 0.7× | 1.6k 0.8× | 1.1k 1.1× | 972 1.1× | 97 | 3.9k | ||
| Earl A. Surwit United States | 32 | 1.3k 0.7× | 1.4k 0.7× | 1.2k 0.6× | 438 0.5× | 566 0.6× | 89 | 3.4k | ||
| Alberto Manetta United States | 32 | 1.3k 0.6× | 1.3k 0.7× | 841 0.4× | 571 0.6× | 561 0.6× | 116 | 3.0k | ||
| Gary L. Goldberg United States | 38 | 1.4k 0.7× | 1.1k 0.6× | 1.0k 0.5× | 990 1.0× | 1.2k 1.4× | 211 | 4.3k | ||
| Gennaro Cormio Italy | 38 | 2.4k 1.2× | 2.6k 1.3× | 1.4k 0.8× | 826 0.9× | 1.1k 1.2× | 306 | 5.6k | ||
| Violante Di Donato Italy | 37 | 1.6k 0.8× | 1.5k 0.8× | 949 0.5× | 752 0.8× | 813 0.9× | 214 | 3.7k | ||
| Hyun Hoon Chung South Korea | 35 | 2.3k 1.1× | 2.0k 1.1× | 712 0.4× | 779 0.8× | 834 1.0× | 169 | 4.3k | ||
| Giorgio Bogani Italy | 42 | 3.8k 1.9× | 3.0k 1.5× | 1.7k 0.9× | 1.2k 1.3× | 1.0k 1.2× | 335 | 6.3k | ||
| Gunter Deppe United States | 27 | 966 0.5× | 941 0.5× | 845 0.4× | 465 0.5× | 622 0.7× | 137 | 2.5k |
Countries citing papers authored by Edward V. Hannigan
Since
Specialization
Citations
This map shows the geographic impact of Edward V. Hannigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward V. Hannigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward V. Hannigan more than expected).
Fields of papers citing papers by Edward V. Hannigan
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Edward V. Hannigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward V. Hannigan. The network helps show where Edward V. Hannigan may publish in the future.
Co-authorship network of co-authors of Edward V. Hannigan
This figure shows the co-authorship network connecting the top 25 collaborators of Edward V. Hannigan. A scholar is included among the top collaborators of Edward V. Hannigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward V. Hannigan. Edward V. Hannigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Alberts, David S., Steve Dahlberg, Stephanie Green, et al.. (2010). Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer: A southwest oncology group study. Cancer. 71(S2). 618–627.
2.
DeFord, James H., et al.. (2008). Implications of tyrosine phosphoproteomics in cervical carcinogenesis. Journal of Carcinogenesis. 7(1). 2–2.
3.
Alberts, David S., Edward V. Hannigan, Caroline S. Jiang, et al.. (2005). Randomized trial of adjuvant intraperitoneal alpha-interferon in stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: An intergroup study. Gynecologic Oncology. 100(1). 133–138.
4.
Benoit, Michelle, Edward V. Hannigan, & Julie Strickland. (2005). Recurrent Mature Cystic Ovarian Teratoma in Adolescence: Atypical Case of the Growing Teratoma Syndrome. Obstetrics and Gynecology. 105(5). 1264–1266.
5.
Scudder, Sidney, Pengfei Liu, Sharon P. Wilczynski, et al.. (2004). Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group. Gynecologic Oncology. 96(3). 610–615.
6.
Dinh, Tung Van, et al.. (2003). Management of Atypical Glandular Cells of Undetermined Significance Pap Smears: A Reappraisal. Journal of Lower Genital Tract Disease. 7(1). 11–15.
7.
Santoso, Joseph T., Edward V. Hannigan, Lyuba Levine, Daneshvari R. Solanki, & M. Mathru. (2001). Effect of Hemodilution on Tissue Perfusion and Blood Coagulation during Radical Hysterectomy. Gynecologic Oncology. 82(2). 252–256.
8.
Rothenberg, Mace L., Sharon P. Wilczynski, Edward V. Hannigan, et al.. (2001). Phase II Trial of Oral Altretamine for Consolidation of Clinical Complete Remission in Women with Stage III Epithelial Ovarian Cancer: A Southwest Oncology Group Trial (SWOG-9326). Gynecologic Oncology. 82(2). 317–322.
9.
Dinh, Tung Van, et al.. (1999). Papanicolaou Smears of Atypical Glandular Cells of Undetermined Significance: Histological Correlations and Suggestions for Management. Journal of Lower Genital Tract Disease. 3(2). 73–76.
10.
Dinh, Tung Van, et al.. (1999). Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix.. PubMed. 44(6). 493–6.
11.
Chopra, Vimlarani, Tung Van Dinh, & Edward V. Hannigan. (1998). Circulating Serum Levels of Cytokines and Angiogenic Factors in Patients with Cervical Cancer. Cancer Investigation. 16(3). 152–159.
12.
Kaspar, Hanna G., Trish Dinh, & Edward V. Hannigan. (1997). Flow cytometry in cervical adenocarcinoma. Correlating DNA content analysis with the clinical picture.. PubMed. 42(3). 170–2.
13.
Alberts, David S., P. Y. Liu, Edward V. Hannigan, et al.. (1996). Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer. New England Journal of Medicine. 335(26). 1950–1955.
14.
Alberts, David S., P. Y. Liu, Edward V. Hannigan, et al.. (1996). Phase III study of intraperitoneal cisplatin-intravenous cyclophosphamide versus intravenous cisplatin-intravenous cyclophosphamide in patients with optimal disease stage III ovarian cancer: a SWOG-GOG-ECOG Intergroup study. International Journal of Gynecological Cancer. 6. 28–28.
15.
Muggia, Franco M., Pengfei Liu, David S. Alberts, et al.. (1996). Intraperitoneal Mitoxantrone or Floxuridine: Effects on Time-to-Failure and Survival in Patients with Minimal Residual Ovarian Cancer after Second-Look Laparotomy—A Randomized Phase II Study by the Southwest Oncology Group. Gynecologic Oncology. 61(3). 395–402.
16.
Alberts, D S, Edward V. Hannigan, Renzo Canetta, et al.. (1994). Cisplatin versus carboplatin in advanced ovarian cancer: An economic analysis. 19(7).
17.
Dinh, Tung Van, et al.. (1993). Chronic plasma cell cervicitis simulating a cervical malignancy: A case report. Obstetrics and Gynecology. 82(4). 646–650.
18.
Alberts, David S., Edward V. Hannigan, Robert V. O’Toole, et al.. (1992). Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.. Journal of Clinical Oncology. 10(5). 706–717.
19.
Amparo, Eugenio G., et al.. (1988). MR Imaging of Uterine Cervical Carcinoma. Journal of Computer Assisted Tomography. 12(3). 409–414.
20.
Nagamani, Manubai, Edward V. Hannigan, Tung Van Dinh, & Charles Stuart. (1988). Hyperinsulinemia and Stromal Luteinization of the Ovaries in Postmenopausal Women With Endometrial Cancer*. The Journal of Clinical Endocrinology & Metabolism. 67(1). 144–148.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hervy E. Averette Breakdown of academic impact, for papers by David H. Moore Breakdown of academic impact, for papers by Earl A. Surwit Breakdown of academic impact, for papers by Alberto Manetta Breakdown of academic impact, for papers by Gary L. Goldberg Breakdown of academic impact, for papers by Gennaro Cormio Breakdown of academic impact, for papers by Violante Di Donato Breakdown of academic impact, for papers by Hyun Hoon Chung Breakdown of academic impact, for papers by Giorgio Bogani Breakdown of academic impact, for papers by Gunter Deppe